Beijing White Flower Loropetalum Biotechnology

Beijing White Flower Loropetalum Biotechnology is a Chinese biopharmaceutical company focused on the development of innovative metabolic disease treatments. The company specializes in the discovery and optimization of multi-target agonists, particularly focusing on the GLP-1, GIP, and Glucagon receptor pathways. Their research aims to address significant unmet needs in chronic conditions such as type 2 diabetes, obesity, and metabolic dysfunction-associated steatohepatitis (MASH). By leveraging advanced peptide and small molecule chemistry, the firm seeks to develop next-generation therapies with improved efficacy and safety profiles.